ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,375
-0,25%
Bitcoin
61 371,29
0,94%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. 23andMe Holding Company (ME)

  7. 23andMe Holding Company (ME) Actualités

ME 23andMe Holding Company

0,505
-0,005 (-0,98%)
11 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
23andMe Holding Company ME NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,005 -0,98% 0,505 06:00:02
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,4911 0,481 0,5139 0,4975 0,51
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/5/202422:06EDGAR2Form 8-K - Current report
09/5/202422:50GLOBE23andMe to Report Q4 and Full Year FY2024 Financial Results
30/4/202417:00BWPotter Handy Law Firm Represents Nearly 5,000 Clients in..
24/4/202422:05GLOBE23andMe to Present Preliminary Efficacy and Biomarker Data..
18/4/202414:00GLOBE23andMe announces CEO’s intention to pursue a potential..
05/4/202422:05GLOBE23andMe to Present Data on Two Clinical Stage..
20/3/202412:30GLOBE23andMe Initiates Phase 1 Clinical Trial for its Dual..
19/3/202413:00GLOBE23andMe Launches New Feature Connecting Customers to..
06/3/202413:30GLOBE23andMe Launches New Genetic Reports on Common Forms of..
05/3/202422:30GLOBE23andMe Announces Three Presentations from Clinical-Stage..
21/2/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202422:03EDGAR2Form 8-K - Current report
07/2/202422:01GLOBE23andMe Reports Third Quarter Fiscal 2024 Financial Results
06/2/202413:00BWMoneta Gold and Nighthawk Gold Complete At-Market Merger to..
31/1/202413:50EDGAR2Form 8-K - Current report
31/1/202404:12GLOBE23andMe Launches Month-Long Initiative to Amplify ARRAY’s..
30/1/202423:00BWNighthawk Gold Obtains Final Court Order for the Proposed..
24/1/202422:05GLOBE23andMe to Report FY2024 Third Quarter Financial Results
22/1/202414:00BWMoneta Gold and Nighthawk Gold Announce the Proposed..
08/1/202413:45EDGAR2Form 8-K - Current report
19/12/202314:00GLOBE23andMe announces further expansion of 23ME-00610 Phase 1/2a..
01/12/202322:06EDGAR2Form 8-K/A - Current report: [Amend]
28/11/202313:15BWNighthawk and Moneta Announce At-Market Merger to Create a..
21/11/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:06EDGAR2Form 8-K - Current report
08/11/202322:29EDGAR2Form 8-K - Current report
08/11/202322:05GLOBE23andMe Reports Second Quarter Fiscal 2024 Financial Results
07/11/202314:00GLOBE23andMe Launches Total Health™, its..
06/11/202314:15EDGAR2Form 8-K - Current report
06/11/202314:00GLOBE23andMe Announces Updated Safety and Preliminary Efficacy..
31/10/202313:00GLOBE23andMe Launches Health Action Plan to Provide Personalized..
30/10/202321:05EDGAR2Form 8-K - Current report
30/10/202313:00GLOBE23andMe Announces Collaboration Extension with a New Data..
27/10/202322:06EDGAR2Form 8-K - Current report
25/10/202322:05GLOBE23andMe to Report FY2024 Second Quarter Financial Results
10/10/202322:17EDGAR2Form 8-K - Current report
27/9/202322:05GLOBE23andMe Announces Poster Presentations on 23ME-00610, an..
19/9/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202322:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202322:06EDGAR2Form 8-K - Current report
15/9/202322:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/9/202313:00GLOBE23andMe and Sickle Cell 101 Collaborate to Expand Sickle..
11/9/202322:06EDGAR2Form 8-K - Current report
08/9/202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202322:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202300:30EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
ME
23andMe
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés